Related Experiment Video
Updated: May 12, 2026
07:54
Cholesterol Efflux Assay
Published on: March 6, 2012
24(S)-hydroxycholesterol is actively eliminated from neuronal cells by ABCA1
Akihiro Matsuda1, Kohjiro Nagao, Michinori Matsuo
1Laboratory of Cellular Biochemistry, Division of Applied Life Sciences, Kyoto University Graduate School of Agriculture, Kyoto, Japan.
Journal of Neurochemistry
|April 23, 2013
Summary
High cholesterol metabolite 24(S)-hydroxycholesterol (24-OHC) is toxic to neurons. ABCA1 transporter actively removes 24-OHC with HDL, protecting brain cells and supporting neural function.
Area of Science:
- Neuroscience
- Cell Biology
- Biochemistry
Background:
- Cholesterol turnover is crucial for brain function, with 24-hydroxylase playing a key role.
- Accumulation of 24(S)-hydroxycholesterol (24-OHC), a product of 24-hydroxylase, can induce neuronal apoptosis.
- Rapid elimination of 24-OHC is vital for neuronal health.
Purpose of the Study:
- To investigate if 24-OHC is actively eliminated from neuronal cells via transporters.
- To determine the role of ATP-binding cassette transporters ABCA1 and ABCG1 in 24-OHC efflux.
- To assess the protective effect of LXR/RXR ligands against 24-OHC toxicity.
Main Methods:
- Differentiated SH-SY5Y neuron-like cells were used as a model system.
- Expression of ABCA1 and ABCG1 was analyzed following 24-OHC or LXR/RXR ligand treatment.
- 24-OHC efflux was measured using high-density lipoprotein (HDL) and apolipoprotein A-I as lipid acceptors.
- siRNA was employed to suppress ABCA1 and ABCG1 expression.
- HEK293 cells stably expressing ABCA1 or ABCG1 were utilized for transporter-specific analysis.
- Primary cerebral neurons were treated with LXR/RXR ligands.
Main Results:
- 24-OHC induced the expression of ABCA1 and ABCG1 transporters.
- 24-OHC efflux was significantly stimulated by HDL when ABCA1 and ABCG1 were expressed.
- siRNA-mediated knockdown of ABCA1, but not ABCG1, suppressed 24-OHC efflux.
- Experiments with HEK293 cells confirmed HDL-mediated 24-OHC efflux via ABCA1.
- LXR/RXR ligand treatment protected primary neurons from 24-OHC-induced toxicity.
Conclusions:
- ABCA1 actively mediates the efflux of 24-OHC in the presence of HDL.
- This ABCA1-dependent mechanism protects neuronal cells from 24-OHC toxicity.
- Targeting ABCA1 and LXR/RXR pathways may offer therapeutic strategies for neurological disorders associated with cholesterol metabolism.
Related Concept Videos
01:29Cholesterol: Significance and Regulation
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
01:23Cholinergic Neurons: Neurotransmission
Cholinergic neurotransmission involves the synthesis and the release of acetylcholine (ACh) in order to transmit nerve impulses across the synapse. The process begins with the synthesis of acetyl CoA, a precursor for ACh, from ATP, acetate, and coenzyme A in the mitochondria. Choline, another vital precursor, is transported inside the neuron through choline transporters, including high-affinity choline transporter CHT1, low-affinity choline transporter CTL1, and lower-affinity choline...
01:23Drug Elimination: Non-Renal Routes
The liver plays a pivotal role in eliminating drugs and their metabolites, primarily through a process known as biliary excretion. This process involves the hepatocytes, the primary cells in the liver that generate bile. A range of transporters actively expels polar drugs or hydrophilic drug metabolites into the bile, which transports the drugs and metabolites into the small intestine. From here, they are eventually expelled from the body through feces. In some instances, the original drug or a...
01:31Direct-Acting Cholinergic Agonists: Pharmacokinetics
Direct-acting cholinergic agonists, such as synthetic choline esters and naturally occurring alkaloids, exert their effects by enhancing the actions of acetylcholine and stimulating the parasympathetic nervous system. Synthetic choline esters share structural similarities with acetylcholine. For example, they have a positively charged quaternary ammonium or onium group, contributing to their hydrophilic characteristics. As a result, they are poorly absorbed in the body through oral...
01:31ABC Transporters: Exporter
ATP-binding cassette or ABC transporter is the largest superfamily of integral membrane proteins. The transporters have transmembrane-binding domains (TMDs) and nucleotide-binding domains (NBDs). The TMDs are specific to their substrates, whereas the NBDs are similar to engines that complete ATP hydrolysis to complete the substrate transport. They can be full transporters consisting of two TMDs and NBDs, half transporters with one TMD and NBD, while some encoded with a single TMD or NBD are...
01:17Hepatic Drug Excretion: Enterohepatic Cycling
Enterohepatic cycling involves the active secretion of drugs and their metabolites into the bile via transporters in the canalicular membrane of hepatocytes. This secretion is an integral part of the digestive process, releasing these substances into the gastrointestinal (GI) tract.
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...